Niels Skjærbæk

Chief Operating Officer at Conrig Pharma ApS

Health Technology

Profile

Niels Skjærbæk is currently the Chief Operating Officer & Director at Conrig Pharma ApS.
Previously, he worked as the Director & Manager-Business Development at Bioneer A.

Niels Skjærbæk active positions

Companies	Position	Start
Conrig Pharma ApS Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark.	Chief Operating Officer	-

All active positions of Niels Skjærbæk

Former positions of Niels Skjærbæk

Companies	Position	End
Bioneer A/S Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark.	Director/Board Member	-

See the detail of Niels Skjærbæk's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Niels Skjærbæk's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Bioneer A/S Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark.	Health Technology
Conrig Pharma ApS Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark.	Health Technology